KALA BIO, Inc. (KALA:NASDAQ) closed at $0.190 on October 23, 2026, up 2.43% on the day. The stock trades 99.8% below its 52-week high of $95.50 and 65.2% above its 52-week low of $0.115. Over the past year, it lost 76.3%. KALA BIO, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 251 trading sessions since October 22, 2025, KALA closed higher on 95 days (38%). Its best day was November 26, 2025 (+42.63%) and its worst was May 7, 2026 (-27.83%). The stock moved 10% or more in a single session 47 times. It opened at least 5% above the previous day's high 6 times.
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Find more stocks like KALA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.